Spread The News

Log in or Register to rate this News Story
Be the first to rate this story!

 

More Industry Headlines

Biomeds urged to 'think beyond the basement' Speakers at AAMI/ECRI Institute meeting offer ways biomeds can get more recognition from the C-suite.

Subscribers only: PACS vendor tries new business model With hospitals' capital budgets depleted by EMR purchases, Merge Healthcare looks to subscriptions.

Medical device tax repeal amendment added to Senate FDA user fee bill Amendment would kill excise tax.

Say no to PSA screenings, USPSTF says Prostate cancer tests do more harm than good, panel says.

Medical groups recommend annual lung CT scans for heavy smokers Should heavy smokers get annual CT lung screenings?

Weird news: Stolen medical equipment contaminated with brain disease Equipment used on Creutzfeldt-Jakob disease patient.

FCC could open spectrum to wireless body sensors FCC to rule on MBANs next week.

VNAs on the rise: forecast Plus, PACS will store a heck of a lot of images by 2016.

World ultrasound sales to grow 29 percent over next 5 years Asia Pacific region to drive sector's growth.

Agfa opens Canadian PACS, RIS R&D center Center opens in Waterloo, Ontario.

Half of U.S. kids treated with proton therapy are under 8

by Brendon Nafziger , DOTmed News Associate Editor
Young children stricken with neurological cancers are among the groups thought to most benefit from high-tech proton therapy. And a new survey suggests they make up the bulk of patients under 18.

Last year, all nine proton therapy centers in the United States treated children, and half of the kids treated were under eight years of age, according to the survey, which was released this week and commissioned by the Pediatric Proton Foundation and the National Association for Proton Therapy. And the overwhelming majority of kids received the therapy for hard-to-treat brain tumors.

Story Continues Below Advertisement
DOTmed Text Ad

NEW! Wireless Foot & Hand Switch for GE-OEC Mobile C-Arms

SPECTRE wireless encrypted foot switch & hand switch for use with GE-OEC Series 9800and 9900 Mobile C-Arms. SPECTRE hand and foot switch work just like the originals - but wirelessly! 800-865-8195


According to the survey, the first to ever create a national portrait of proton therapy use in kids, 465 children and teenagers underwent proton therapy treatments in 2010. Of these patients, 53 percent were under eight, with about one-third between one and four years old.

Nearly three-quarters of the tumors afflicted the brain or brainstem, and nearly one out of five involved the skull, head or neck. Six percent involved the abdomen or pelvis, and three percent the axial skeleton (which includes the upper spine and chest).

The most common tumor -- present in 71 cases -- was an ependymoma, a kind of cancer of the central nervous system.

Although all operating centers treat children, 66 percent of patients in the survey were treated at just three centers: Massachusetts General Hospital in Boston, M.D. Anderson Cancer Center in Houston and University of Florida's Proton Therapy Institute in Jacksonville.

Another key finding of the study was the need for multidisciplinary teams. Half of the most common tumors required concurrent chemotherapy treatment, and half of the young patients had to be anesthetized during their therapy.

Nonetheless, the study acknowledged some limitations: for instance, the researchers didn't always have full detail on the tumor's site or subsite, and the ICD-9 codes they used weren't always reliable.

Benefits for children

Proton therapy uses precisely controlled blasts of radiation to scramble the DNA of cancer cells. Because of the way protons operate, less radiation reaches healthy tissue.

The centers that offer this treatment are expensive, often costing tens of millions of dollars to build. But many researchers think children and adolescents can benefit from the more precise dosing of protons, as they're more radiosensitive than adults.

Limiting the "exit dose" during treatment is also believed to be especially useful for pediatric neurological tumors, as traditional radiation therapies have been linked with later cognitive deficits and attention disorders, according to the NAPT.

The study was presented at the Children's Oncology Group meeting in Atlanta this week by Dr. Daniel Indelicato, a radiation oncologist with the University of Florida.

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment


 Login
  OR  
 Register

Not a DOTmed User?

Registration is Free and Easy.

Enjoy the benefits of
The World's Leading
New & Used Medical Equipment Marketplace

Register Now!


Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2012 DOTmed.com, Inc.
ALL RIGHTS RESERVED